News
OrthoAccel - $750,000 -
February 28, 2008
Houston-based
OrthoAccel
Technologies, Inc., was awarded $750,000 to
further develop and commercialize its
orthodontic device, the Celerect. The
Celerect is a revolutionary device, based on a
technology that cuts treatment time for braces
in half.
OrthoAccel was the winner of
BioHouston's 2007 Michael E. Debakey Life
Science Award, and is a joint client of both the
Houston Technology Center Acceleration program
and BioHouston. Click
here for more...
StarVision - $750,000 -
January 9, 2008
StarVision Technologies,
Inc., a Research Valley-based aerospace research
and development company, was awarded $750,000 to
help complete its SpeedStar product, a
revolutionary new altitude determination sensor
system that improves the performance and reduces
costs for satellites.
The company will become a
joint client of both the Houston Technology
Center Acceleration program and the
Research Valley
Innovation Center, a science and technology
incubator/accelerator recently established by
the Research Valley Partnership and various
Texas A&M University System entities. Click
here for more...
Bellicum Pharmaceuticals
- $1,450,000 - October 9,
2007
Bellicum
Pharmaceuticals, Inc., a pharmaceutical
company, was awarded $1,450,000 to help
develop its next generation therapeutic
vaccines for the treatment of cancer, based
on technology developed at Baylor College of
Medicine. Click
here for more...
Laser Tissue Welding
- $160,000 - October 9,
2007
Laser Tissue Welding, Inc., a
biotherapeutic company, was awarded $160,000
to help develop its innovative sutureless
surgical therapies using human serum albumin
based biodegradable biomaterials to join,
repair and create homeostasis on surfaces of
solid viscera organs such as the liver,
spleen and kidney involved in trauma, cancer
and transplantation even in the presence of
coagulation failure or therapeutic
anticoagulation. Click
here for more...
Thrombovision
- $1,500,000 - October 9,
2007
ThromboVision, Inc., a biomedical
diagnostics company was awarded $1,500,000
to help develop its ThromboGuide Platelet
Function Analyzer. Click
here for more...
Visualase
- $750,000 - October 9,
2007
Visualase,
Inc., a biomedical diagnostics company, was
awarded $750,000 to help develop its
Visualase Thermal Therapy System, a
revolutionary tool for destructive treatment
of cancer or other malignancies using
patented laser and MRI-based guidance
systems. Click
here for more...
Lynntech receives $600,000 ETF Award,
May 9, 2007
Lynntech, Inc., a research
and development company, has been awarded
$600,000 to help develop its high power,
hydrogen/air fuel cell technology. Click
here for more...
PLx Pharma receives $2M ETF Award,
March 16, 2007
PLx Pharma, a pharmaceutical
company, has been awarded $2,000,000 to help
develop new formulations for safer and more
effective non-steroidal anti-inflammatory drugs
(NSAIDs) currently on the market, such as
Aspirin and Ibuprofen. PLx will use a
platform technology licensed from the University
of Texas Health Science Center in Houston and
will focus on reducing the potential life
threatening gastrointestinal toxicities related
with chronic use of NSAIDs. Click
here for more...
Molecular LogiX
receives $794,520 ETF Award,
March 16, 2007
Molecular LogiX has been
awarded $794,520 to develop a "first in class"
therapeutic cancer treatment. This
treatment will optimze the company's Pan-HER
Anti-Cancer Ligand, a genetically engineered
version of the naturally occurring growth
hormone that blocks the cell receptor necessary
for growth of tumor cells. In addition to
providing oncologists and their patients with a
new, more robust drug to treat cancer, this drug
has the potential to be the first of a new
family of drugs to treat other diseases
resulting from abnormal ligand receptor
interactions.
Molecular LogiX has been
working in collaboration with scientists from
the Baylor College of Medicine and University of
Texas M. D. Anderson Cancer Center, assisted by
the South Montgomery County Woodlands Economic
Development Partnership. Click
here for more...
NanoComposites receives $1.5M ETF Award,
October 4, 2006
NanoComposites has been
awarded $1,500,000 to commercialize its proprietary
process for the functionalization of carbon
nanotubes. In 2007, NanoComposites will be
producing uniquely enhanced elastomers for use
in mission critical seals used in upstream oil
and gas drilling operations. NanoComposites
has been working in collaboration with Rice
University and assisted by the Greater Houston
Partnership. Click
here for more...
Nanospectra Biosciences receives $1.25M ETF
Award,
October 4, 2006
Nanospectra Biosciences has
been awarded $1,250,000 to fund the clinical
development of its AuroLease Cancer Therapy.
Nanospectra's primary focus is the development
and commercialization of AuroLase, which is
broadly applicable to virtually all solid
tumors. Nanospectra Bioscience's
collaboration partners are Rice University, UT
MD Anderson Cancer Center, UTMB at Galveston and
the Greater Houston Partnership. Click
here for more...
CNAP/CNI receives $975,000 ETF Award,
October 4, 2006
The Carbon Nanotube
Acceleration Project (CNAP), an operating
division of Carbon Nanotechnologies, Inc. (CNI)
has been awarded $975,000 to help bring to
market a new fuel cell technology that is
expected to power the next generationof portable
and wireless electronic devices. The
technology was developed by the late Nobel Prize
Laureate in Chemistry, Professor Rick Smalley,
at Rice University. CNAP's collaboration
partners are Rice University and the Economic
Development Alliance for Brazoria County. Click
here for more...
Endothelix receives $1M ETF Award,
July 21, 2006
Endothelix has been awarded $1,000,000 for the development of its low-cost
non-invasive VENDYS procedure, a new technology
for the measurement of vascular reactivity, a
marker of endothelial dysfunction, by monitoring
temperature at one's fingertips. Endothelix's first technology was licensed from
the Texas Heart Institute and the University of
Texas Health Science Center in Houston.
Researchers from the University of Houston,
Baylor College of Medicine and Texas A&M
University are also actively involved with
Endothelix. Click
here for more...
itRobotics receives $750,000 ETF Award,
July 21, 2006
itRobotics has been awarded $750,000 for the development of robotic
in-line inspection systems for tubular plant
equipment and non-piggable pipelines, developed
in collaboration with Rice University.
itRobotics' application was sponsored by the
Greater Fort Bend Economic Development Council.
Click
here for more...
CorInnova receives $500,000 ETF Award,
June 1, 2006
CorInnova has been awarded $500,000 for the development of heart
assist technologies that lead to heart recovery
rather than heart replacement. The core
technology is a device that enhances heart
recovery through restoration of proper cardiac
motion. This is a Texas A&M University
technology invented by Dr. John Criscione,
CorInnova's CEO. CorInnova's application
was sponsored by the Research Valley
Partnership. Click
here for more...
Moneymakers article in Houston Chronicle -
March 16, 2006
Click
here to see an interview with Aruna
Viswanathan, Vice President and Director of
Operations, for the Houston Technology Center in the Houston Chronicle.
HTC Selected to serve as Gulf Coast RCIC -
September 8, 2005
The Houston
Technology Center (HTC) announced on Friday that
it has been selected, in collaboration with
Greater Houston Partnership (GHP) and all the
Economic Development Organizations (EDO) within
its region, to serve as the Gulf Coast Regional
Center of Innovation and Commercialization (RCIC)
for the Texas Emerging Technology Fund (TETF).
The Gulf Coast RCIC will service
30 counties in
its region and accept all funding applications
for energy and technology companies within its
region.
The TETF was created in June 2005 when Governor
Rick Perry signed House Bill 1765 allocating
$200 million for the fund whose goals are to
improve research at Texas universities, assist
small to mid-size technology firms to launch
sooner and significantly reduce the time it
takes to move new life-changing inventions out
of the lab and into the hands of consumers.
“Supporting emerging technologies in Texas will
help us cultivate and keep our home-grown
technologies and also attract new business and
research. This will create new jobs and enhance
our competitive position as a global technology
leader” Said Mark Ellison, Director of the
Emerging Technology Program. He added: “The
program will also encourage stronger
collaboration and greater synergies between the
numerous economic organizations within each
region”.
Eight RCICs will assist the administration of
the fund by receiving applications from
individuals and companies, researching each
application and submitting recommendations to
the Texas Emerging Technology Committee. The
committee will then make its recommendations to
the Governor, Lt. Governor and Speaker who will
determine quarterly which projects will be
funded.
“HTC is pleased to expand its outreach to
include College Station, Galveston, Beaumont,
Port Arthur and many other locales. While we
have the infrastructure in place to serve as a
focal point, we will build on input from all the
various partners in the program. Our success
will depend on the collaborative effort of all
the organizations involved” said Paul Frison,
President and CEO of the Houston Technology
Center. “We are thrilled to see such support for
emerging technology companies from the Governor
and are committed to help the program as much as
we can”, he added.
Governor Rick Perry and Mark Ellison will be
featured speakers at the HTC Technology Showcase
in October and discuss the new Texas Emerging
Technology Fund.
Houston Technology Center (HTC) accelerates the
commercialization of emerging technology
companies in Houston. A 501(C)(3) corporation
and the center of entrepreneurship in Houston,
HTC assists Houston-based entrepreneurs within
several key sectors: Energy, Information
Technology, Life Sciences, Nanotechnology and
NASA-originated technologies.
|